Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration

N/AUnknownNCT06119139

Cairo University70 enrolled

Overview

The aim of the study is to compare the anesthetic efficacy and need for supplemental anesthesia of 1.8 ml compared to 3.6 ml of 4% articaine buccal infiltration in mandibular molars with symptomatic irreversible pulpitis.

Patients with moderate-to-severe pain due to symptomatic irreversible pulpitis will be included. Patients will be randomly assigned into two groups to receive either 1.8 ml 4% articaine buccal infiltration or 3.6. ml 4% articaine buccal infiltration before single visit root canal treatments. Intraoperative pain will be assessed using an 11-point numerical rating scale (NRS) so that anesthetic success will be defined as no to mild intraoperative pain. The need for supplemental anesthesia will also be recorded.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

Conditions

Symptomatic Irreversible Pulpitis

Interventions

3.6 ml 4% Articaine hydrochlorideDRUG

3.6 ml 4% articaine buccal infiltration

1.8 ml 4% Articaine hydrochlorideDRUG

1.8 ml 4% articaine buccal infiltration

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Healthy patients who are categorized as I or II according to The American Society of Anesthesiologists (ASA class I or II). 2. No sex predilection 3. Patients with symptomatic irreversible pulpitis 4. Patient with the ability to understand and use pain scales. 5. Patients who accept to enroll in the study. Exclusion Criteria: 1. Patients' allergies to any of the drugs or materials used in the study. 2. Pregnant and lactating females. 3. Patients taking analgesics in the last 6-8 hours. 4. Patients having more than one symptomatic tooth in the same quadrant

Outcomes

Primary Outcomes

Anesthetic success

Will be measured by 11-point numerical rating scale NRS. The success will be defined as no or mild pain (NRS 0 or less than 3) and the failure will be defined as moderate to severe pain (NRS more than 3).

Time frame: During the procedure

Secondary Outcomes

Need for supplemental anesthesia

Whether the patient requires supplemental anesthesia or not. It will be recorded by the questionnaire (yes or no).

Time frame: During the procedure

Central Contacts

Hebatullah Moheb Ibrahim

CONTACT

00201114563058 heba.eid@dentistry.cu.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.